CLL/SLL

Oncology·MeSH: Leukemia, Lymphocytic, Chronic, B-Cell

5 drugs in development·3 companies·3 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
brukinsa	BeOne Medicines Ltd. (ONC)

Phase 3(3)

Drug	Company
bexobrutideg	Nurix Therapeutics, Inc. (NRIX)
btk inhibitor	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
lisaftoclax +btk inhibitor	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

Phase 1(1)

Drug	Company
lisaftoclax	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)

BioSniper tracks 5 drugs in development for CLL/SLL across 3 companies.

There are 3 clinical trials targeting CLL/SLL tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.